Cash & equivalents increased 50.7%
Cash & equivalents changed +50.7% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +50.7% from the comparable as-filed period.
Gross margin changed +1425 basis points from the comparable as-filed period.
Gross profit changed +28.3% from the comparable as-filed period.
Inventory changed +25.0% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Operating income changed +22.5% from the comparable as-filed period.
Operating margin changed +708 basis points from the comparable as-filed period.
Research & development changed +483.3% from the comparable as-filed period.
Selling, general & administrative changed +20.4% from the comparable as-filed period.
Stock-based compensation changed +23.6% from the comparable as-filed period.
Net income changed +10.5% from the comparable as-filed period.
Revenue changed +2.0% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.